Cart
sales@molnova.com
CW069
CAS No. 1594094-64-0
CW069 ( CW069; CW-069; CW 069 )
Catalog No. M18087 CAS No. 1594094-64-0
CW069(IC50=75 μM), an allosteric selective inhibitor of microtubule motor protein HSET, exhibits remarkable specificity over KSP.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 91 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 264 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 500MG | 1071 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCW069
-
NoteResearch use only, not for human use.
-
Brief DescriptionCW069(IC50=75 μM), an allosteric selective inhibitor of microtubule motor protein HSET, exhibits remarkable specificity over KSP.
-
DescriptionCW069 is an allosteric inhibitor of HSET. CW069 showed marked activity against HSET in vitro. The inhibitor induced multipolar mitoses only in cells containing supernumerary centrosomes. CW069 therefore constitutes a valuable tool for probing HSET function and, by reducing the growth of cells containing supernumerary centrosomes, paves the way for new cancer therapeutics.
-
SynonymsCW069; CW-069; CW 069
-
PathwayOthers
-
TargetOther Targets
-
RecptorHSET
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1594094-64-0
-
Formula Weight500.33
-
Molecular FormulaC23H21IN2O3
-
Purity98%
-
SolubilityDMSO : ≥ 52 mg/mL; 103.93 mM
-
SMILESO=C(O)c1cc(I)ccc1NC(=O)[C@@H](NCc1ccccc1)Cc1ccccc1
-
Chemical Name5-Iodo-2-[[(2S)-1-oxo-3-phenyl-2-[(phenylmethyl)amino]propyl]amino]-benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Watts CA, et al. Chem Biol. 2013, 20(11), 1399-1410.
molnova catalog
related products
-
MART-1 (26-35) human
MART-1 (26-35) human is amino acid residue 26 to 35 of MART-1 protein.
-
Allocryptopine b
Allocryptopine has certain effects on anti-injury for hepatocyte, ameliorating liver function, and prohibiting hepatic fibrosis; it increases mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR.
-
PACMA 31
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
